Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Erik Gamelin"'
Autor:
Anne-Marie Vidal, F. Grude, Christian Riche, Jean-Philippe Metges, Jean-Yves Douillard, Réjane Bessard, Erik Gamelin, Hugues Bourgeois
Publikováno v:
Bulletin du Cancer. 100:271-282
Optimizing the care management of patients is a major issue for our society. In Brittany-Pays-de-la-Loire (almost 10% of French population), an observatory of cancer has been created in 2003. Its main objective was the follow-up of expensive drugs. T
Autor:
Eric Jadaud, Philippe Menei, Guy G, D. Fournier, Marie-Claire Venier, Jean-Pierre Benoit, Philippe Mercier, Erik Gamelin, Jean-Paul Saint-André, Ghassan Hayek
Publikováno v:
Cancer. 86:325-330
BACKGROUND The authors have developed a new method of drug delivery into the brain using implantable biodegradable microspheres. In this study, this method was used to provide localized and sustained delivery of 5-fluorouracil (5-FU) after the surgic
Autor:
Françoise, Grudé, Réjane, Bessard, Hugues, Bourgeois, Jean-Yves, Douillard, Erik, Gamelin, Jean-Philippe, Metges, Christian, Riché, Anne-Marie, Vidal
Publikováno v:
Bulletin du cancer. 100(3)
Optimizing the care management of patients is a major issue for our society. In Brittany-Pays-de-la-Loire (almost 10% of French population), an observatory of cancer has been created in 2003. Its main objective was the follow-up of expensive drugs. T
Autor:
Suzanne, Nguyen, Christine, Rebischung, Johan, Van Ongeval, Michel, Flesch, Mustapha, Bennamoun, Thierry, André, Marc, Ychou, Erik, Gamelin, Elisabeth, Carola, Christophe, Louvet
Publikováno v:
Bulletin du cancer. 93(1)
We evaluated the Epitax combination (epirubicin 60 mg/m2 and docetaxel 75 mg/m2, every 3 weeks) in advanced gastric cancer (AGC) as second-line treatment after fluorouracil and platinum in 50 patients, then as first-line treatment in 36 patients. We
Autor:
Martine Mege, Jean-Pierre Benoit, V G Roullin, Erik Gamelin, Laurent Lemaire, Jean-Pierre Cueyssac, Philippe Menei, Marie-Claire Venier-Julienne
Publikováno v:
Pharmaceutical Research
Pharmaceutical Research, American Association of Pharmaceutical Scientists, 2004, 21 (9), pp.1558-1563. ⟨10.1023/b:pham.0000041448.22771.48⟩
ResearcherID
Pharmaceutical Research, American Association of Pharmaceutical Scientists, 2004, 21 (9), pp.1558-1563. ⟨10.1023/b:pham.0000041448.22771.48⟩
ResearcherID
To determine (i) the efficiency of radiosensitizing 5-FU-loaded microspheres and (ii) the impact of microparticle formulation on response to treatment.C6 tumor-bearing rats were stereotactically implanted with microspheres and/or allocated to: contro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e78afc45de51115e2c5634b16242bf14
https://hal.univ-angers.fr/hal-02375468
https://hal.univ-angers.fr/hal-02375468